title: Call for Elan to publish Alzheimer's trial details.
authors.forename: Glenda M
authors.initials: GM
authors.lastname: Bishop
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Robinson
authors.forename: Mark A
authors.initials: MA
authors.lastname: Smith
authors.forename: George
authors.initials: G
authors.lastname: Perry
authors.forename: Craig S
authors.initials: CS
authors.lastname: Atwood
mesh_terms: D000544:Alzheimer Disease / Q000150:complications / Q000276:immunology* / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000009:adverse effects* / Q000276:immunology / Q000627:therapeutic use; D000818:Animals; D002490:Central Nervous System / Q000276:immunology / Q000473:pathology; D002986:Clinical Trials as Topic / Q000009:adverse effects*; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D007249:Inflammation / Q000139:chemically induced / Q000150:complications; D051379:Mice; D011643:Publishing
chemical_list: C437846:AN-1792; D016229:Amyloid beta-Peptides